Karyopharm Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
Karyopharm Therapeutics last closed at $0.6050 (+0.83%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -0.1×. Its overall grade ranks 344 of 736 stocks in Healthcare.
About this company
Karyopharm Therapeutics last closed at $0.6050 (+0.83%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 344/736
Valuation grade A-
Related stocks
- CelgeneCustomer
다발골수종 치료제 익사조밋 계열 상업화 협력 이력
- Bristol Myers SquibbCustomer
Celgene 인수 후 익사조밋 관련 상업화 파트너
- AmgenCompetitor
다발골수종·혈액암 치료제 영역에서 경쟁
About Karyopharm Therapeutics
- What technical signals does Karyopharm Therapeutics (KPTI) have?
- Karyopharm Therapeutics current technical signals: no active technical signal.
- Is Karyopharm Therapeutics a cup-and-handle pattern?
- No. Karyopharm Therapeutics has no valid Cup signal right now.
- What published figures are available for Karyopharm Therapeutics?
- Market cap: $10.32M. Trailing 12 months PER: -0.1×. Latest quarter PBR: -0.05×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about Karyopharm Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.